Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.58 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.46 |
| ▸ | SPHK2 | Q9NRA0 | 6/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.44 |
| ▸ | PRKCG | P05129 | 2/20 | 0.44 |
| ▸ | PRKCB | P05771 | 2/20 | 0.44 |
| ▸ | PRKCA | P17252 | 2/20 | 0.44 |
| ▸ | PRKCH | P24723 | 2/20 | 0.44 |
| ▸ | PRKCI | P41743 | 2/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413367 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL16995925 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL28757032 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL873108 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL2102930 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL1668988 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL10514828 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL14779258 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL15560286 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 | |
| SCHEMBL27821359 | 1.00 | ALDH1A1 (0.62) | ALDH1A1EPHX1SPHK1SPHK2PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636262-B2 | Process for the preparation of topical formulation | Neuheit Pharma Technologies Pvt. Ltd. (IN) | 2026-05-26 | — | — | US | claimed |
| US-12527729-B2 | Minoxidil adjuvant therapies | CARING BRANDS, INC. (US) | 2026-01-20 | — | — | US | claimed |
| US-20240224994-A1 | INSECT REPELLANT FORMULATION AND METHOD OF USING SAME | UNITED INDUSTRIES CORPORATION | 2024-07-11 | — | — | US | claimed |
| US-20230404886-A1 | MINOXIDIL ADJUVANT THERAPIES | Jupiter Wellness, Inc. (US) | 2023-12-21 | — | — | US | claimed |
| US-11730831-B2 | Imaging agents and methods of using the same | SICREATIONS, LLC (US) | 2023-08-22 | — | — | US | claimed |
| WO-2022251534-A1 | INSECT REPELLENT FORMULATION AND METHOD OF USING SAME | UNITED INDUSTRIES CORPORATION (US) | 2022-12-01 | — | — | WO | claimed |
| US-20220265577-A1 | PROCESS FOR THE PREPARATION OF ANTHRAQUINONE TOPICAL FORMULATION | NEUHEIT PHARMA TECHNOLOGIES PVT. LTD (IN) | 2022-08-25 | — | — | US | claimed |
| CN-114404424-A | A pharmaceutical composition for treating alopecia, and its preparation method | 硬核医药科技(上海)有限公司 | 2022-04-29 | — | — | CN | claimed |
| US-20200323998-A1 | IMAGING AGENTS AND METHODS OF USING THE SAME | SICREATIONS, LLC | 2020-10-15 | — | — | US | claimed |
| WO-2020198534-A1 | IMAGING AGENTS AND METHODS OF USING THE SAME | SICREATIONS, LLC (US) | 2020-10-01 | — | — | WO | claimed |
| CN-1229696-A | Catalyst for conversion of ethylene into light alpha olefins | INST FRANCAIS DU PETROLE (FR) | 1999-09-29 | — | — | CN | claimed |
| US-5942545-A | Composition and method for treating penile erectile dysfunction | MACROCHEM CORPORATION (US) | 1999-08-24 | — | — | US | claimed |
| WO-1999009954-A1 | NON-STEROIDAL ANTIINFLAMMATORY DRUG FORMULATIONS FOR TOPICAL APPLICATION TO THE SKIN | MACROCHEM CORPORATION (US) | 1999-03-04 | — | — | WO | claimed |
| CN-1195580-A | Improved catalytic composition and process for converting ethylene to light alpha olefins | INST FRANCAIS DU PETROLE (FR) | 1998-10-14 | — | — | CN | claimed |
| EP-0552879-B1 | Improved iontophoretic administration of drugs | MACROCHEM CORP (US) | 1998-08-19 | — | — | EP | claimed |
| EP-0578541-B1 | Process for the preparation of light alpha-olefines by oligomerisation of ethylene | INST FRANCAIS DU PETROLE (FR) | 1997-12-03 | — | — | EP | claimed |
| EP-0728462-A2 | Cosmetic method and composition for treating hair loss | MacroChem Corporation (US) | 1996-08-28 | — | — | EP | claimed |
| US-5496783-A | CATALYSIS WITH MIXTURE OF ZIRCONIUM COMPOUND, ACETAL OR KETAL, AND ORGANOALUMINUM BROMIDE OR CHLORIDE | INSTITUT FRANCAIS DU PETROLE (FR) | 1996-03-05 | — | — | US | claimed |
| US-5345023-A | Zirconium coordination catalysts with acetals and ketals | INSTITUT FRANCAIS DU PETROLE (FR) | 1994-09-06 | — | — | US | claimed |
| EP-0552879-A1 | Improved iontophoretic administration of drugs | MACROCHEM CORPORATION (US) | 1993-07-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527729-B2 | Minoxidil adjuvant therapies | RXRA, RXRB, RXRG | ALDH1A1 2373/4885EPHX1 2134/4885SPHK1 995/4885 |
| US-20220265577-A1 | PROCESS FOR THE PREPARATION OF ANTHRAQUINONE TOPICAL FORMULATION | RFTN1, DSTN, TREH | ALDH1A1 2327/4885EPHX1 1111/4885SPHK1 312/4885 |
| US-12636262-B2 | Process for the preparation of topical formulation | LRAT, LIPA, DSG1 | ALDH1A1 3989/4885EPHX1 962/4885SPHK1 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.